Association of Serum Bilirubin Levels with Macro- and Microvascular Complications in Chinese People with Type 2 Diabetes Mellitus: New Insight on Gender Differences
暂无分享,去创建一个
Lin Li | Yan-jiao Wang | Yi Wang | Youshuo Liu | Junkun Zhan | Shuang-Jiang Li | Niman Li
[1] Qinhui Liu,et al. Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target , 2022, Frontiers in Immunology.
[2] Bo Peng,et al. Lifestyle and chronic kidney disease: A machine learning modeling study , 2022, Frontiers in Nutrition.
[3] R. Takayanagi,et al. Association of serum total bilirubin levels with progressive renal decline and end-stage kidney disease: 10-year observational cohort study in Japanese patients with diabetes , 2022, PloS one.
[4] George J. Dugbartey,et al. Activation of renal CSE/H2S pathway by alpha-lipoic acid protects against histological and functional changes in the diabetic kidney. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] Zhangsuo Liu,et al. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy , 2022, Frontiers in Endocrinology.
[6] J. Björkegren,et al. Atherosclerosis: Recent developments , 2022, Cell.
[7] H. Bao,et al. Association of Plasma Bilirubin Levels With Peripheral Arterial Disease in Chinese Hypertensive Patients: New Insight on Sex Differences , 2022, Frontiers in Physiology.
[8] P. Reddy,et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. , 2022, Free radical biology & medicine.
[9] Zhengming Chen,et al. Menopausal status, age at natural menopause and risk of diabetes in China: a 10-year prospective study of 300,000 women , 2022, Nutrition & Metabolism.
[10] Xiaomei Dong,et al. Dose-Response Association Between Bilirubin and Cardiovascular Disease: A Systematic Review and Meta-analysis , 2022, Angiology.
[11] Jinbao Liu,et al. Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system , 2022, Journal of translational medicine.
[12] V. Novack,et al. The Association of Alanine Aminotransferase Levels With Myocardial Perfusion Imaging and Cardiovascular Morbidity , 2022, Journal of cardiovascular pharmacology and therapeutics.
[13] J. Olefsky,et al. Inflammation in obesity, diabetes, and related disorders. , 2022, Immunity.
[14] Zane C. Giffen,et al. Serum bilirubin as a predictor of graft outcomes after renal transplant. , 2022, American journal of clinical and experimental urology.
[15] T. Yasu. Comprehensive cardiac rehabilitation program for peripheral arterial diseases. , 2021, Journal of cardiology.
[16] A. El-Kadi,et al. Sex differences in eicosanoid formation and metabolism: A possible mediator of sex discrepancies in cardiovascular diseases. , 2021, Pharmacology & therapeutics.
[17] M. Bechara,et al. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors , 2021, Diabetes/metabolism research and reviews.
[18] W. Rathmann,et al. Incidence Rates and Predictors of Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes: Results from the Longitudinal Global DISCOVER Study. , 2021, American heart journal.
[19] J. Xia,et al. Serum Bilirubin Levels and Extent of Symptomatic Intracranial Atherosclerotic Stenosis in Acute Ischemic Stroke: A Cross-Sectional Study , 2021, Frontiers in Neurology.
[20] Huafang Li,et al. Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia , 2021, BMC Psychiatry.
[21] Y. Jeong,et al. The Anti-Inflammatory Role of Bilirubin on “Two-Hit” Sepsis Animal Model , 2020, International journal of molecular sciences.
[22] Hongyu Wang,et al. The Relationship Between Serum Bilirubin Levels and Peripheral Arterial Disease and Gender Difference in Patients With Hypertension: BEST Study , 2020, Angiology.
[23] J. Shaw,et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.
[24] P. Zhong,et al. Total bilirubin is negatively related to diabetes mellitus in Chinese elderly: a community study. , 2019, Annals of translational medicine.
[25] Ximin Fan,et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study , 2019, Cardiovascular diabetology.
[26] Miao Liu,et al. The U-Shaped Association between Bilirubin and Diabetic Retinopathy Risk: A Five-Year Cohort Based on 5323 Male Diabetic Patients , 2018, Journal of diabetes research.
[27] Jian Wang,et al. Inverse Relationship Between Serum Bilirubin Levels and Diabetic Foot in Chinese Patients with Type 2 Diabetes Mellitus , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[28] Christine Maric-Bilkan. Sex differences in micro- and macro-vascular complications of diabetes mellitus. , 2017, Clinical science.
[29] Miao Liu,et al. Elevated serum total bilirubin levels are negatively associated with major diabetic complications among Chinese senile diabetic patients. , 2017, Journal of diabetes and its complications.
[30] M. Mahfouz,et al. Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[31] K. Kohara,et al. Association between Serum Bilirubin and Estimated Glomerular Filtration Rate among Diabetic Patients , 2015, International scholarly research notices.
[32] P. Smits,et al. The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[33] R. Takayanagi,et al. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. , 2010, Kidney international.
[34] S. Ito,et al. Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease , 2009 .
[35] N. Nakamura,et al. Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. , 2008, Kidney international.
[36] Solomon H. Snyder,et al. Biliverdin reductase: A major physiologic cytoprotectant , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.